Lupus & Connective Tissue Diseases
From the Journals
High-need, high-cost lupus patients described for first time
The identification of this group “will help pave the way to develop programs that improve the quality of care for high-risk lupus patients,”...
Conference Recap
A Review of ACR Convergence Abstracts on Systemic Lupus Erythematosus
Dr Michele Petri highlights abstracts on systemic lupus erythematosus from ACR 2020, including ...
Conference Coverage
Slow taper off antimalarial is best to avoid lupus flare during remission
“Except in the setting of toxicity, cessation of antimalarial medication in patients with disease quiescence is feasible using a slow taper,” said...
Conference Coverage
Chronic inflammatory diseases vary widely in CHD risk
The highest coronary heart disease risks linked to inflammation are seen in SLE and systemic sclerosis, conditions that aren’t included in...
Conference Coverage
Sjögren’s symptom clusters may identify treatment options
Patients with Sjögren’s syndrome can be grouped into one of four symptom clusters that can inform research and potentially targeted therapies.
Conference Coverage
Methotrexate users need tuberculosis tests in high-TB areas
Those taking corticosteroids or other immunosuppressants are at particularly high risk, a systematic review of literature finds.
Conference Coverage
Pregnancy can be safe with interstitial lung disease
Often women with ILD related to an autoimmune disease are advised to avoid conception or terminate their pregnancies. But the largest study to...
Conference Coverage
COVID-19 risks in rheumatic disease remain unclear
Elevated COVID-19-related risks, many associated with comorbidities, emerged in a match-control study, whereas a systematic review delivers more...
Conference Coverage
Lupus-specific predictors for CVD described in Black patients
Discoid rash and renal disorder predicted stroke, and neurologic and immunologic disorder predicted ischemic heart disease in Black patients with...
From the Journals
Transcutaneous VNS on the ear shows positive effects in lupus pilot trial
Promising improvements in musculoskeletal pain, fatigue, and swollen and tender joints were reported with stimulation.
Conference Coverage
COVID-19–related HCQ shortages affected rheumatology patients worldwide
Data from the Global Rheumatology Alliance Patient Experience Survey presented at ACR Convergence 2020 demonstrate that the severity of shortages...